← Open Payments lookup

DONNA SMITH: Open Payments

NPI 1396744231 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,281 in 63 payments from 17 companies in 2025. Trend: 2023 $879 · 2024 $1,112 · 2025 $1,281

Food & beverage: $1,281
CompanyPaymentsAmount
Janssen Biotech, Inc.14$270
ABBVIE INC.11$237
Takeda Pharmaceuticals U.S.A., Inc.13$187
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$116
PFIZER INC.3$76
Ipsen Biopharmaceuticals, Inc3$66
GENZYME CORPORATION2$55
QOL Medical, LLC2$53
Madrigal Pharmaceuticals2$46
Aimmune Therapeutics, Inc.1$34

Products named: TREMFYA, ENTYVIO, RINVOQ, XIFAXAN, IQIRVO, LINZESS, DUPIXENT, Sucraid.

Industry payments across VA — which companies pay providers there.